Clinical Trial Detail

NCT ID NCT03673124
Title Ribociclib and Letrozole Treatment in Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Gynecologic Oncology Group
Indications

ovarian serous carcinoma

peritoneal carcinoma

Therapies

Letrozole + Ribociclib

Age Groups: adult senior

No variant requirements are available.